He Ministry of Health funds a unique treatment that reduces effective and sustained cholesterol thanks to a vaccine. IT caring for people at risk that they are not able to lower their figures bad cholesterol less than 100 mg/dl through exercise and diet. Despite this, patients must continue to take their cholesterol medications to treat their condition.
The injection, according to pharmaceutical company Novartis, contains the active ingredient Leqvio which reduced cholesterol in 54% of patients with atherosclerotic cardiovascular diseaseThe drug in the vaccine interferes with RNA and limits the production of bad cholesterol (LDL).
Patients vaccinated against bad cholesterol in Spain
He cholesterol is a natural fat which passes through the blood and If levels are above 200 mg/dl, bad cholesterol is created.leading to cardiovascular diseases. These types of diseases are the leading cause of death in Spain. Data provided by the INE indicate that in 2021 119,196 people died from this type of diseaseor 26.4% of total deaths. They are also the leading cause of hospitalization with 12.9% (582,446 admissions) in 2021.
THE atherosclerotic cardiovascular disease It is produced by the accumulation of lipids, mainly LDL cholesterol, bad cholesterolin the inner wall of the arteries.
THE Vaccination against bad cholesterol only requires two doses per year. With the injection, the production of PCSK9 in the liver will be inhibited.
Side effects of the bad cholesterol vaccine in Spain
THE side effects According to clinical trials, they are benign. Can affects one in 10 people and their reactions can be pain, redness and rash where the injection was given. Patients must continue to take their prescribed cholesterol pills and the Department of Health will fund them as long as the drug treatment continues.
